Bachamanda Somesh, Dipthi
Klose, Kristin http://orcid.org/0000-0003-4502-6389
Maring, Janita A.
Kunkel, Désirée
Jürchott, Karsten
Protze, Stephanie I.
Klein, Oliver
Nebrich, Grit
Becker, Matthias
Krüger, Ulrike
Nazari-Shafti, Timo Z.
Falk, Volkmar
Kurtz, Andreas
Gossen, Manfred
Stamm, Christof http://orcid.org/0000-0003-3035-2106
Funding for this research was provided by:
Helmholtz Association (Programme-oriented funding)
German Research Foundation (Through the Berlin‐Brandenburg School for Regenerative Therapies GSC 203)
Charité – Universitätsmedizin Berlin (Doctoral research stipend, Doctoral research stipend)
German Federal Ministry of Education and Research (1315848A, 1315848B, 13GW0098, 13GW0099)
Charité - Universitätsmedizin Berlin
Article History
Received: 24 March 2022
Accepted: 25 September 2023
First Online: 15 October 2023
Declarations
:
: All animal procedures, including surgery, follow-up examinations, and sacrifice, were approved by the State Office of Health and Social Affairs Berlin (wildtype and <i>Myh6</i>-mCherry cell isolation, approval no.: T0158/15, project title: killing notice, approval date: 06-22-2015; C57BL/6 J myocardial infarction model, approval no.: G0288/16, project title: epicardial hybrid patch, approval date: 02-02-2017) and conducted in accordance with the Directive 2010/63/EU of the European Union, the German Animal Welfare Act, and the Charité Animal Welfare Guidelines. The manuscript adheres to the ARRIVE guidelines (ExternalRef removed) for the reporting of animal experiments. Not applicable.
: Not applicable.
: The authors declare no conflict of interest.